Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones. - Wikidata - wikimedia - TriplyDB

Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.

Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.

http://www.wikidata.org/entity/Q38604890

about

New antimycobacterial agents in the pre-clinical phase or beyond: recent advances in patent literature (2001-2016).Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections.Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones.Therapeutic challenges posed by critical drug-drug interactions in cystic fibrosis.Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.Auto-Tandem Catalysis in Ionic Liquids: Synthesis of 2-Oxazolidinones by Palladium-Catalyzed Oxidative Carbonylation of Propargylic Amines in EmimEtSO₄.Novel therapeutic approaches of natural oil from black seeds and its underlying mechanisms against kidney dysfunctions in haloperidol-induced male rats.Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation.Potential Drug-Drug Interactions with Antimicrobials in Hospitalized Patients: A Multicenter Point-Prevalence Study.

P2860

Q30243915-2436BAE2-F3F4-47D8-B512-376E5DE7BE47 Q33438834-B4EE9DFE-128C-4375-B1CB-90D3C9AF98B1 Q38777085-5D1E5BD1-59A2-4026-8E3E-064D4B516A57 Q38962747-255C854A-E6D1-434C-8679-43DE93BDA229 Q39067666-64D7AD5F-715C-42D3-B959-D4CAAA53F5B6 Q41864236-722BA1CE-7C86-4F33-B1CF-536D2EBA5644 Q46518239-4CF071F4-8DF3-43A7-B638-9F04658F6433 Q51068947-697DFD76-1AD4-458C-BEA9-5282A0FEB265 Q53698038-22449390-7B1D-47FB-8AFF-DEBDA264E998 Q55646748-BB8B4592-9622-44E5-BBBC-87058B2BA9C7

P2860

Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.

http://www.wikidata.org/entity/Q38604890

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.

@en

type

label

Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.

@en

prefLabel

Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.

@en

P1433

Q38604890-99C66C37-8F8A-45E4-A844-E2A028A525EE

P1476

Q38604890-6A5649D7-592C-49C9-AB89-A6123AA7853C

P2093

Q38604890-7F577C01-D703-4E90-A28C-76EB90E31A39

Q38604890-91CBB358-4AA8-47BA-A09E-CAF88C33E293

P2860

Q38604890-007B468F-EA5A-49E0-B125-CC4228D98D03

Q38604890-05E37603-EE8A-4618-8020-E04F315F9DCE

Q38604890-086257EA-F535-467F-AD75-5174F2AC6738

Q38604890-12539048-CDB6-49E3-862A-BE6564BF2E41

Q38604890-1801F29B-45EC-4835-BA68-EC814504BE38

Q38604890-1AA33E08-6B74-49E9-AA2C-253959A620D7

Q38604890-1B53A8BD-66A2-49D3-B9EB-208CDEB8D7E1

Q38604890-24C20FFB-B3EC-4FA5-8125-09ED530BFA5A

Q38604890-24FEF5DF-18C7-43D2-A7C7-307A6EDE0D35

Q38604890-27D90A40-EE0B-4708-A3DD-AEC7C2A0D245

P304

Q38604890-B31CB39E-6120-4882-8F70-E2FA328DF3B8

P31

Q38604890-18F96C23-A5B6-4C3B-BCDD-210C8B474229

P356

Q38604890-5AF30368-BC33-43E7-ADFA-7C9C013A23CF

P407

Q38604890-40CA9202-BC35-46FD-9654-462B58549334

P433

Q38604890-DCD692CF-1F24-492C-95F1-CDCDD2400C15

P478

Q38604890-82C1F7CB-6BDF-443A-83F5-39279EFFCAC4

P50

Q38604890-86C4DA08-7996-46A7-8194-66A45B6EC8CB

P577

Q38604890-F75834E6-5A13-4DE1-A29F-5CFCDEA5F552

P698

Q38604890-9BC29078-CE85-4EE9-8CE0-1CD8F5CDD4D7

P356

17425255.2015.1098617

P1433

Expert Opinion on Drug Metabolism & Toxicology

P1476

Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.

@en

P2093

Katja Grabowski

http://www.w3.org/2001/XMLSchema#string

Ralf Stahlmann

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action of the oxazolidinone antibacterial agents

Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.

Hematologic effects of linezolid: summary of clinical experience.

High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease.

Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.

Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study

Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?

Intrapulmonary pharmacokinetics of linezolid

Linezolid--a review of the first oxazolidinone.

P304

1849-1859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.2015.1098617

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Antonios Douros

P577

2015-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26457865

http://www.w3.org/2001/XMLSchema#string